Andy Chen's Stock Ratings

Wolfe Research Analyst

Andy Chen is an analyst at Wolfe Research. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/04/2025

Overall Average Return

-7.70%

Smart Score

39.5%

Overall Average Return Percentile

23rd

Number of Ratings

36
Data brought to you by Benzinga APIs

Recent Analyst Stock Rating News

This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
This Expand Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
What Analysts Are Saying About Celldex Therapeutics Stock
Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock
This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
This Airbnb Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday
The Latest Analyst Ratings For Kymera Therapeutics
Analyst Expectations For Celldex Therapeutics's Future
Co. Says Geoprobe Drilling Found 'Consistent' Lithium, Boron Concentrations
Source: Streetwise Reports 10/15/2024
The Analyst Landscape: 7 Takes On Kymera Therapeutics
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2025 Benzinga | All Rights Reserved